A coalition of developers has petitioned the European Commission, saying Apple's revised App Store fees continue to ...
Masimo Corporation’s stock has reached a 52-week low, trading at 133.66 USD. This marks a significant decline for the company, which has seen its stock price fall by 22.49% over the past year. The ...
StockStory.org on MSN
Masimo (MASI) Stock Is Up, What You Need To Know
Shares of medical tech company Masimo (NASDAQ:MASI) jumped 3.5% in the morning session after the company presented an upbeat long-term financial outlook at its 2025 Investor Day, prompting positive ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders ...
Hosted on MSN
Masimo unveils long-term strategy at investor day
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Dec. 5, 2025 ...
Invesco Small Cap Equity Fund underperformed in Q3 2025 despite strong small-cap returns. Click here to learn about our ...
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Masimo ( (MASI) ) has provided an update.
Zacks Investment Research on MSN
Masimo (MASI) is a top-ranked growth stock: Should you buy?
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
Medtech industry groups said the FDA should use existing regulatory and quality tools to monitor performance, while medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results